Business

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for individuals with spinal cord injury Reimbursement coverage is expected to give Lifeward stronger revenue and cash flow dynamics to scale growth MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 03, 2025 (GLOB

articleLifeward Ltd.December 3, 20256/company/rewalk-robotics-ltd/news/lifeward-broadens-reimbursement-coverage-rewalk-130000140
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

About this update from Lifeward Ltd.

[{"type":"image","alt":"Lifeward Ltd.","displaySize":"","headline":null,"caption":"Lifeward Ltd.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":214,"url":"https://media.zenfs.com/en/globenewswire.com/650bbdd4116421044d82c00fb4f6ebe6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wsdrGKJN7fPKThSBzlEhlA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/650bbdd4116421044d82c00fb4f6ebe6","width":300,"height":214}},"lazy":false},{"type":"text","content":"Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees","length":191,"tagName":"p"},{"type":"text","content":"This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for individuals with spinal cord injury","length":139,"tagName":"p"},{"type":"text","content":"Reimbursement coverage is expected to give Lifeward stronger revenue and cash flow dynamics to scale growth ","length":107,"tagName":"p"},{"type":"text","content":"MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that it received prior authorization from Humana Medicare Advantage Plan for a ReWalk 7 Personal Exoskeleton. This marks the second national Medicare Advantage Plan, following UnitedHealthcare a few weeks ago, to make the important decision to support members living with spinal cord injury by facilitating access to this life-changing technology.","length":638,"tagName":"p"},{"type":"text","content":"By approving coverage for the ReWalk 7 under its Medicare Advantage Plan, Humana continues to show leadership in embracing innovative medical technologies and widening reimbursement pathways for beneficiaries. The approval reflects Humana’s dedication to meeting the needs of members with disabilities and their families, providing more reliable and predictable access to personal exoskeletons as part of a comprehensive care strategy.","length":435,"tagName":"p"},{"type":"text","content":"“Nationally nearly half of all Medicare Advantage enrollees a...

More updates from Lifeward Ltd.

Medicare AdvantageLifeward Ltdprior authorizationthe CompanyCompanyMedicare